Khashayar Dashtipour

← Back to Loma Linda University

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease

   2007 · 206 citations

2. Diffusion, spread, and migration of botulinum toxin

   2013 · 202 citations

3. Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature

   2012 · 182 citations

4. Speech Disorders in Parkinson’s Disease: Pathophysiology, Medical Management and Surgical Approaches

   2018 · 149 citations

5. Ultrastructural features and synaptic connections of hilar ectopic granule cells in the rat dentate gyrus are different from those of granule cells in the granule cell layer

   2001 · 115 citations

6. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

   2024 · 106 citations

7. Expression of active caspase‐3 in mitotic and postmitotic cells of the rat forebrain

   2001 · 93 citations

8. Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level

   2003 · 87 citations

9. Effect of Exercise on Motor and Nonmotor Symptoms of Parkinson’s Disease

   2015 · 81 citations

10. Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial

    2017 · 79 citations

11. Transdermal Rotigotine: A Clinically Innovative Dopamine‐Receptor Agonist for the Management of Parkinson's Disease

    2009 · 73 citations

12. Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults

    2020 · 68 citations

13. Localization of leptin receptor splice variants in mouse peripheral tissues by immunohistochemistry

    1998 · 61 citations

14. Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms

    2018 · 58 citations

15. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach

    2017 · 56 citations

16. Abo‐, Inco‐, Ona‐, and Rima‐Botulinum Toxins in Clinical Therapy: A Primer

    2013 · 49 citations

17. VMAT2 inhibitors for the treatment of hyperkinetic movement disorders

    2020 · 49 citations

18. Temporal profile of hilar basal dendrite formation on dentate granule cells after status epilepticus

    2003 · 47 citations

19. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity

    2014 · 45 citations

20. Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease

    2015 · 41 citations

21. Chapter 25 Neuroplasticity in the damaged dentate gyrus of the epileptic brain

    2002 · 40 citations

22. OnabotulinumtoxinA Injection for Poststroke Upper‐Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process

    2016 · 40 citations

23. Quantitative and morphological analysis of dentate granule cells with recurrent basal dendrites from normal and epileptic rats

    2002 · 37 citations

24. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials

    2018 · 37 citations

25. OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review

    2015 · 32 citations

← Return to the university profile